Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Impact of IL17 A Gene Polymorphismson Egyptian Patients with Multiple Myeloma.

Asian Pacific journal of cancer prevention : APJCP - 1 Jul 2023

Mortada Metwaly Ibrahim, Shahin Doaa, Abousamra Nashwa, Aladle Doaa Abdalla, El-Ashwah Shaimaa, Ghobrial F E I, El-Baiomy M A, Soliman Eman A, A Niazy Nermeen, Ghannam Mayada A

Abstract excerpt

INTRODUCTION: Multiple myeloma (MM) is a B-cell lymphoproliferative disease in which the bone marrow microenvironment plays an important role in pathogenesis. The T helper (Th-17) cell plays an important role in the development of cancer by releasing pro-inflammatory cytokines such as IL-17A and IL-17F. Th-17 cells have been studied in a variety of solid tumors, as well as few hematological malignancies,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Egypt

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Interleukin-17

Share to Multiple Myeloma

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 37505775
DOI: 10.31557/APJCP.2023.24.7.2421
PMCID: PMC10676498

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Impact of IL17 A Gene Polymorphismson Egyptian Patients with Multiple Myeloma.PMID 37505775Read ↗

IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma.Semantic proximity Read ↗

IL-17/miR-192/IL-17Rs Regulatory Feedback Loop Facilitates Multiple Myeloma ProgressionSemantic proximity Read ↗

Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients.Semantic proximity Read ↗

Correlation between acute myeloid leukemia and IL-17A, IL-17F, and IL-23R gene polymorphism.Semantic proximity Read ↗

Effect of Cytokine Genes in the Pathogenesis and on the Clinical Parameters for the Treatment of Multiple Myeloma.Semantic proximity Read ↗

Genetic polymorphisms and multiple myeloma risk: a meta-analysis.Semantic proximity Read ↗

Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib.Semantic proximity Read ↗

Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.Semantic proximity Read ↗

IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia.Semantic proximity Read ↗

C950T and C1181G osteoprotegerin gene polymorphisms in myeloma bone disease.Semantic proximity Read ↗

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy.Semantic proximity Read ↗

The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.